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Cellular senescence is a cell fate characterized by an irreversible cell cycle arrest, but the molecular mechanism
underlying this senescence hallmark remains poorly understood. Through an unbiased search for novel senescence
regulators in airway basal cells, we discovered that the epigenetic regulator ubiquitin-like with PHD and ring finger domain-
containing protein 1 (UHRF1) is critical for regulating cell cycle progression. Upon injury, basal cells in the mouse airway
rapidly induce the expression of UHRF1 in order to stimulate stem cell proliferation and tissue repair. Targeted depletion of
Uhrf1 specifically in airway basal cells causes a profound defect in cell cycle progression. Consistently, cultured primary
human basal cells lacking UHRF1 do not exhibit cell death or differentiation phenotypes but undergo a spontaneous
program of senescence. Mechanistically, UHRF1 loss induces G1 cell cycle arrest by abrogating DNA replication factory
formation as evidenced by loss of proliferating cell nuclear antigen (PCNA) puncta and an inability to enter the first cell
cycle. This proliferation defect is partially mediated by the p15 pathway. Overall, our study provides the first evidence of an
indispensable role of UHRF1 in somatic stem cells proliferation during the process of airway regeneration.
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Introduction
Cellular senescence represents a fundamental cell
fate that has critical physiological roles in develop-
ment, stem cell biology and wound healing, and
pathological roles in tumorigenesis and aging [1–7].
Thus, the study of cellular senescence at the mechan-
istic level could help us further elucidate the key
determinants of cell fate specification and also
reinforce our understanding of senescence-associated
physiological and pathological conditions. Epigenetic
regulation has a profound impact on many biological
processes. Previous studies have implicated that
epigenetic alterations occur during the senescent
process and direct manipulation of epigenetic factors
may change the outcome of cellular senescence [8–10].
The molecular identity of epigenetic regulators having
critical roles in modulating the senescent process,
however, remains largely unknown.
Human diploid fibroblasts are the most common
cell type used in the senescent studies, whereas the
functional importance of epithelial cell senescence is
less investigated. Our lab has previously shown that
epidermal growth factor receptor inhibition is sufficient
to induce cellular senescence in human bronchial
epithelial (HBE) cells [11], which function as basal stem
cells in the airway. The conducting airways of the
human lung are lined by a pseudostratified epithelium
composed of luminal cells and undifferentiated basal
stem cells. Immunohistochemistry analysis of airway
epithelium has revealed that basal cells are cytokeratin
5 (KRT5) positive [12]. Those KRT5+ basal stem cells
remain quiescent at steady state, but upon injury they
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replenish the wound by self-renewal and then give rise
to early progenitor cells to further differentiate into
luminal cells to reconstruct to the homeostatic state.
This regeneration process is precisely controlled in a
spatio-temporal manner, and disruption of the balance
between basal cell proliferation and differentiation
invariably results in pathological conditions, such as
chronic obstructive pulmonary disease [13]. Discovery
of the underlying mechanisms of epithelium regenera-
tion by airway basal cells could shed light on the
etiology of relevant respiratory diseases.
Using unbiased gene expression profiling, we found
that the ubiquitin-like with PHD and ring finger
domain-containing protein 1 (UHRF1) was severely
reduced upon the induction of various forms of HBE
cellular senescence. UHRF1 is a 90 kD multidomain
protein known to bind methylated histones and hemi-
methylated DNA, which also possesses ubiquitin ligase
activity by virtue of its carboxyl-terminal RING finger
domain [14–16]. Knockout of Uhrf1 in mice is
embryonic lethal with embryos exhibiting extreme
growth retardation, and Uhrf1− /− embryonic stem cells
have pronounced DNA hypomethylation, especially
in heterochromatin regions and retrotransposon
elements [14]. Previous research implicates the essential
functions of UHRF1 in regulating the proliferation,
survival and differentiation of colonic regulatory
T cells, invariant natural killer T cells and hemato-
poietic stem cells [17–19]. Loss of UHRF1 in neural
stem cells in the developing cerebral cortex results in a
postnatal neurodegeneration phenotype because of
increased cell death [20]. Collectively, accumulating
data suggest that UHRF1 has multiple biological
functions dependent on cellular context. The function
of UHRF1 in epithelial stem cell systems, however,
has not been investigated.
Here, we show that UHRF1 expression is dynami-
cally regulated during the regeneration of the muco-
ciliary epithelium from airway basal cells in vivo and in
three-dimensional organoid cultures. Targeted deletion
of Uhrf1 in basal stem cells results in cell cycle arrest
and defective proliferation after injury without affect-
ing cell survival or inducing premature differentiation.
Importantly, UHRF1 downregulation in cultured
HBE cells is sufficient to induce premature cellular
senescence, and UHRF1’s capacity to suppress senes-
cence is mainly dependent upon its ability to promote
cell cycle progression. Therefore, our study compre-
hensively defines the function of UHRF1 in airway
basal cells and the molecular mechanisms underlying
UHRF1-mediated senescence suppression, with rele-
vance to epithelial stem cell self-renewal and disease.
Results
UHRF1 is downregulated in several senescent contexts
and UHRF1 knockdown is sufficient to induce epithelial
cell senescence
To discover novel regulators of the senescent
phenotype, we used an established model of cellular
senescence comprised of sustained epidermal growth
factor receptor inhibition in HBE cells [11]. Cells
treated with erlotinib or dimethylsulfoxide were
incubated with the fluorescent senescence-associated
beta-galactosidase (SA-β-Gal) substrate C12FDG, and
senescent cells were purified using flow cytometry
according to the method of Debacq-Chainiaux et al.
[21] and Yuan (in preparation). Subsequent gene
expression analysis revealed significantly reduced
expression of the epigenetic regulators CBX5, HELLS
and UHRF1 in the senescent population compared
with the non-senescent and dimethylsulfoxide controls
(Supplementary Figure S1a). Quantitative real-time
PCR validation confirmed that the expression of
HELLS and UHRF1 was strongly repressed as early as
18 h after senescence induction, whereas CBX5 down-
regulation was less robust and observed only at the
48-h time point (Supplementary Figure S1a). Notably,
UHRF1 mRNA is also significantly decreased in
replicative and oncogene-induced senescence based on
two published gene expression data sets (GSE19864
and GSE19018). We confirmed the reduced protein
expression of UHRF1 in these three senescent contexts
using oncogenic H-Ras-overexpressing senescent
IMR90 fibroblasts, late passage HBE cells and epi-
dermal growth factor receptor inhibition-induced
senescent HBE cells (Supplementary Figure S1b). To
determine the functional significance of these findings,
HELLS or UHRF1 expression was reduced using short
hairpin RNA (shRNA)-mediated knockdown in HBE
cells. Depletion of HELLS had no significant effect on
HBE cell senescence as measured by Edu incorporation
and SA-β-Gal staining (data not shown), which is
consistent with previous findings in human fibroblasts
[22]. In contrast, UHRF1 knockdown resulted in major
impairments in cell growth (Figure 1f), mimicking the
induction of cellular senescence triggered by epidermal
growth factor receptor inhibition. Based on these
results, we selected UHRF1 as a possible epigenetic
regulator of the senescent state.
To investigate a possible role in suppressing
senescence, we first used shRNA to deplete UHRF1
in IMR90 fibroblasts, a commonly used cell type
in senescent studies, and observed morphological
changes, cell growth arrest, and SA-β-Gal activity
Basal stem cell proliferation
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Figure 1 Loss of UHRF1 in IMR90 and HBE cells leads to a senescent phenotype. (a) Cell proliferation was measured by EdU
incorporation in control (shNT) or UHRF1 knockdown IMR90 cells 6 days after virus transduction. (b, c) SA-β-gal staining of
control and UHRF1 knockdown IMR90 cells (b) and quantification (c). (d, e) Whole-cell lysates from control, UHRF1 knockdown,
or UHRF1 and p53 co-knockdown IMR90 cells were collected and subsequently immunoblotted with the indicated antibodies.
Cells were collected 6 days after virus transduction. Note that p21 expression in UHRF1-deficient cells correlates with p53
induction. (f) Cell proliferation was measured by EdU incorporation in control (shNT) or UHRF1 knockdown HBE cells in
culture 6 days after virus transduction. (g, h) Representative SA-β-gal staining is shown in g, and quantification is shown in h.
(i) Whole-cell lysates from control (shNT) or the UHRF1 knockdown HBE cells (shU_1 and shU_2) from three independent
donors were collected and subsequently immunoblotted with the indicated antibodies. Data are reported as mean± s.e.m.
P-value was calculated based on at least three independent experiments. ***Po0.001; **Po0.01; *Po0.05.
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consistent with the induction of senescence (Figure 1a–c).
Moreover, the canonical cyclin-dependent kinase
inhibitors p15, p16, p21 and p53 were all upregulated
as a result of UHRF1 knockdown (Figure 1d).
Although UHRF1 has been previously reported to
regulate the methylation status of the Cdkn1a distal
promoter [17, 23], combinatorial targeting of UHRF1
and p53 abolished the induction of p21 (Figure 1e),
indicating that p21 upregulation primarily depends on
p53 status in UHRF1-deficient IMR90 cells.
We next examined the consequence of UHRF1 loss
in primary HBE cells isolated from lung tissue of
human donors, the cell type we used in our initial
screen. As in IMR90 fibroblasts, UHRF1 knockdown
in HBE cells resulted in the appearance of non-
dividing, SA-β-Gal-positive senescent cells (Figure 1f–h).
To examine the senescence-associated molecular
alterations induced upon UHRF1 depletion, we
utilized HBE cell populations obtained from
three healthy human donors. Interestingly, whereas
upregulation of p53 and p21 was variable among the
three batches, p15 expression was uniformly increased
as a consequence of UHRF1 loss (Figure 1i), suggest-
ing that p15 is a critical regulator of UHRF1 depletion-
induced senescence in HBE cells. We also tested
whether UHRF1 knockdown-induced cellular
senescence was due to DNA damage responses. We
stained γH2AX foci in control and senescent UHRF1
knockdown HBE cells collected 6 days after UHRF1
shRNA-lentiviral infection and did not see an
increase of γH2AX levels in senescent HBE cells
from the UHRF1 knockdown group (Supplementary
Figure S1c). Indeed, targeted knockdown of p15 was
found to partially rescue the loss of proliferative
capacity and increased SA-β-Gal activity phenotypes
resulting from UHRF1 depletion (Supplementary
Figure S2e–h), whereas downregulation of p53 could
not reverse any senescence-associated phenotypes
(Supplementary Figure S2a–d). The changes of p15
levels may not be due to DNA methylation, as bisulfite
sequencing analysis of the CDKN2B core promoter
showed no statistically significant changes in DNA
methylation (Supplementary Figure S2i). Together,
these results indicate that UHRF1 suppresses cellular
senescence in multiple human cell types.
UHRF1 is dynamically regulated and associated with
basal stem cell proliferation during airway regeneration
We next sought to determine the physiological
relevance of these findings. HBE cells function as air-
way stem cells that can proliferate and differentiate
into both secretory cells and ciliated cells in response to
airway injury [12, 13]. A previous study demonstrated
that Uhrf1 is among the genes most highly upregulated
in response to sulfur dioxide (SO2)-induced airway
injury (Supplementary Figure S3), although the
functional significance of UHRF1 induction for the
airway repair process was not explored [24]. To
investigate this, we exposed mice to 500 parts
per million (p.p.m.) of SO2 for 4 h, which results in
depletion of differentiated luminal cells expressing
KRT8. These differentiated cells are replenished over
the next 5 days to 2 weeks by the proliferation
and differentiation of basal cells expressing KRT5
(Figure 2a). In agreement with the gene expression
analysis, immunohistochemical staining revealed that
UHRF1 protein was strongly induced in KRT5+ basal
cells at 24 and 48 h after injury, which coincides with
basal cell expansion, and later downregulated upon
completion of the differentiation process (Figure 2b).
Moreover, co-staining with Ki67 demonstrated a
nearly complete coincidence of proliferating cells and
UHRF1 expression (Figure 2c and d), suggesting that
UHRF1 is actively involved in the process of basal cell
expansion in response to airway injury.
To test the correlation between UHRF1 expression
and human airway regeneration, we took advantage of
a three-dimensional tracheosphere culture system in
which human basal cells are grown under conditions
that favor the formation of spherical organoids
containing both basal and differentiated luminal cell
types [12] (Figure 3a and b). On day 7, visible spheres
were already present in the culture, suggesting the rapid
proliferation of single HBE cells. From 2 weeks to
1 month, the cells of each tracheosphere started
to differentiate, establish apical–basal polarity and
self-organize to create a stratified epithelium with
luminal cells pointing toward the lumen. In this setting,
UHRF1 was expressed in a subset of KRT5+ basal
cells but excluded from KRT8+ luminal cells in differ-
entiated spheres (Figure 3c), which is consistent with
our earlier evidence linking UHRF1 to basal cell
expansion in the damaged trachea. Importantly, EdU
incorporation revealed that UHRF1 was expressed
exclusively in basal cells undergoing replication during
the early expansion stages of tracheosphere formation
(Figure 3d).
Loss of UHRF1 leads to irreversible cell cycle arrest and
impairs proliferation of basal cells after injury
We next interrogated the functional ramification of
UHRF1 in regulating proliferation and regeneration
of HBE cells. We first knocked down UHRF1 with
shRNA (shU_1 and shU_2) in early-passage HBE
Basal stem cell proliferation
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cells. The cells were subsequently seeded in the
Matrigel for tracheosphere formation. On day 7, visible
spheres could be seen in the control group (shNT),
whereas UHRF1 knockdown groups derived much
fewer spheres (Figure 4a and b), suggesting there was a
significant decrease in the colony-forming efficiency
of cells lacking UHRF1 compared with controls.
Proliferation defect was mainly attributed to the
abrogation of sphere formation, as UHRF1 knock-
down cells in culture also had much reduced EdU
incorporation rate (Figure 1f). The same finding was
made with CRISPR/Cas9 genome-editing technology
Figure 2 UHRF1 expression is tightly correlated with cell proliferation during airway epithelium repair. (a) Illustration representing
the repair of the mouse tracheal epithelium by basal stem cells after SO2 injury. (b) Confocal images of mouse trachea epithelium
collected at steady state, 24 h, 48 h and 5 days after SO2 injury. Longitudinal midline sections stained with antibodies to KRT5
(basal cell marker), KRT8 (differentiated luminal cell and early progenitor cell marker) and UHRF1. Note that UHRF1 expression
was undetectable at steady state but was markedly upregulated after injury. (c) Confocal images of mouse trachea epithelium
collected at steady state, 24 and 48 h after SO2 injury. Tissue sections were co-stained with UHRF1 and Ki67, a proliferation
marker. (d) Quantification of the percentage of Ki67+UHRF1+, Ki67+UHRF1−, Ki67−UHRF1+, Ki67−UHRF1− in total cells in the
epithelium. Scale bar: 20 μm.
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to knockout UHRF1: we utilized two guide RNAs to
knockout UHRF1, respectively, and the tracheosphere
formation capability in UHRF1-knockout cells was
significantly declined (Supplementary Figure S4a). We
subsequently stained those spheres formed in UHRF1-
knockout group with UHRF1 antibody and found that
basal cells in the spheres expressed UHRF1, indicating
that spheres formed in UHRF1-knockout groups were
derived from clones without successful deletion of
UHRF1 (Supplementary Figure S4b).
Since a previous report has demonstrated that
UHRF1 controls self-renewal versus differentiation of
hematopoietic stem cells through epigenetic regulation,
we examined if UHRF1 loss in HBE cells could drive
premature differentiation by the air–liquid interface
(ALI) culture, a well-established differentiation assay
for basal cells [25]. To test this, we plated out control
and UHRF1 knockdown cells and tracked two
well-established differentiation markers: acetyl-tublin
for ciliated cells and MUC5AC for goblet cells at early
time point. We did not observe the presence of both
markers in UHRF1 knockdown cells or control cells
2 weeks after seeding, although both markers were
heavily upregulated in the positive controls that were
well-differentiated ALI cultures from unmanipulated
HBE cells (Supplementary Figure S5a). These data
demonstrated that UHRF1 deficiency does not drive
premature differentiation and that the impact of
UHRF1 on stem cell differentiation is likely tissue
specific. In addition, knockdown of UHRF1 in HBE
Figure 3 UHRF1 expression pattern in the three-dimensional tracheosphere assay. (a) Schematic for the three-dimensional
organoid culture system. HBE cells were mixed with fibroblasts in growth factor reduced Matrigel. (b) Representative microscopic
images of tracheosphere cultures at days 7, 14 and 28. Single basal cells proliferated and self-renewed to form visible spheres
within 1 week, and spheres began to differentiate after 2 weeks. (c) Confocal images of individual spheres collected at indicated
time points to show the expression levels of UHRF1, KRT5 and KRT8. (d) Confocal images of individual spheres collected at
indicated differentiation time points stained with the UHRF1 antibody and the EdU click-it imaging kit. Spheres were incubated
with EdU for 5 h before staining. UHRF1 was expressed in all detectable EdU-positive cells. Scale bars: 20 μm.
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cells did not affect cell viability indicated by Annexin V
and propidium iodide (PI) staining (Supplementary
Figure S5b). Treating UHRF1-deficient HBE cells
with a pan-caspase inhibitor (Z-VAD-FMK) had no
effect on sphere formation, suggesting apoptotic death
was not the reason for the lack of sphere formation in
HBE cells (Supplementary Figure S5c and d). Toge-
ther, these results indicate that UHRF1 is essential for
tracheosphere formation by virtue of its requirement
for basal cell proliferation.
To rigorously test whether UHRF1 is necessary for
basal cell expansion in vivo, we utilized a conditional
mouse model in which CreER expression is specifically
restricted to KRT5-expressing cells, allowing for
inducible Cre-Lox recombination in a basal cell-
specific manner. Intraperitoneal tamoxifen injection
followed by SO2-mediated airway injury in Uhrf11
fl/fl;
K5-CreER mice resulted in heterogeneous UHRF1
expression in the KRT5+ basal cell layer 24 h after the
injury (Figure 4c and d), indicative of partial gene
knockout in line with previous studies [25, 26].
This procedure led to severely reduced basal cell pro-
liferation as measured by Ki67 staining. Importantly,
proliferating Ki67-positive cells were uniformly those
that maintained UHRF1 expression (Figure 4e and f),
suggesting that basal cells lacking UHRF1 are
incapable of proliferating to repair the damaged
epithelium after injury.
Figure 4 UHRF1 is required for the proliferation of basal cells in airway epithelium repair and three-dimensional tracheosphere
culture. (a) Representative microscopic images of the tracheosphere culture from control (shNT) or UHRF1 knockdown (shU_1
and shU_2) primary HBE cells. Images were taken 7 days after seeding. (b) Quantification of the percentage of colony formation
efficiency of each group from a. Data are reported as mean± s.e.m. **Po0.01, P-value was calculated based on three
independent experiments. (c) Schematic of loss-of-function (Uhrf1fl/fl;K5-CreER) model. K5-CreER mice and Uhrf1fl/fl;K5-CreER
were i.p. injected with four doses of Tmx. One week after the last injection, mice were exposed to SO2, and tracheas were
harvested at 24 h after injury. (d) Representative confocal images of tracheas stained with UHRF1 and KRT5 antibodies in control
(K5-CreERT) and loss-of-function (Uhrf1fl/fl;K5-CreER) mice. Cells in the epithelium were all KRT5+, indicating the success of the
injury. (e) Representative confocal images of tracheas stained for UHRF1 and Ki67 control (K5-CreERT) and loss-of-function
(Uhrf1fl/fl;K5-CreER) mice. The percentage of UHRF1+Ki67+ cells significantly decreased in Uhrf1fl/fl;K5-CreER mice.
(f) Quantification of the percentage of each indicated cell population. Data are reported as mean± s.e.m. *Po0.05, three mice
per group. Scale bar: 20 μm.
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UHRF1 deficiency results in a senescence-associated
gene signature and genome-wide DNA hypomethylation
The results described above show that UHRF1 is
necessary for the maintenance of HBE cell division,
and this function is required for the reconstitution of
the bronchial epithelium by basal stem cells after
lung injury. At the molecular level, UHRF1 has been
shown to coordinate histone modifications with DNA
methylation, chromatin marks that ultimately function
to regulate gene expression. To gain mechanistic
insight into the requirement of UHRF1 for basal stem
cell maintenance, we performed global gene expression
analysis of HBE cells lacking UHRF1 using RNA-Seq
(Figure 5a). Subsequent gene ontology analysis
indicated that downregulated genes were mainly
involved in cell cycle progression, with the most highly
represented pathways consisting of the mitotic cell
cycle, nuclear division, DNA replication and G1/S
phase transition (Figure 5b). These results were
unsurprising given our previous observations that
UHRF1 is necessary to suppress HBE cellular senes-
cence, but provide additional evidence that UHRF1
functions chiefly as a regulator of cell cycle progression.
Interestingly, pathways upregulated as a result of
UHRF1 knockdown were involved predominantly in
immune and inflammatory responses (Figure 5c). This
finding likely reflects the induction of a senescence-
associated secretory phenotype, which is a common
property of senescent cells that can have pleiotropic
effects on surrounding tissue [27]. Indeed, the levels of
several major cytokines known to be commonly
involved in the senescence-associated secretory
phenotype, including interleukin-6 and interleukin-8,
were induced following the loss of UHRF1 in the
RNA-Seq data (Figure 5c). Therefore, UHRF1
appears to regulate a broad program of cellular
senescence consisting of both stable cell cycle arrest and
the generation of a senescence-associated secretory
phenotype.
The SRA domain of UHRF1 is known to preserve
cytosine methylation following DNA replication via
concomitant binding of hemi-methylated DNA and the
maintenance methyltransferase DNMT1. A recent
study reports that UHRF1 can suppress IMR90
fibroblast senescence, and senescence induced by
UHRF1 knockdown is partially dependent on reduced
expression of DNMT1 [28]. To examine global DNA
methylation changes induced by UHRF1, we per-
formed DNA dot blot assays using a 5-methylcytosine
antibody. This assay was validated using the cytosine
analog 5-azacitidine, which caused dose-dependent
decreases in the abundance of 5-methylcytosine in
HeLa cells (Figure 5d). Like 5-azacitidine, UHRF1
knockdown in unsynchronized HBE cells using two
independent shRNAs resulted in broadly defective
DNA methylation as measured by 5-methylcytosine
staining (Figure 5e). However, as our RNA-seq data
revealed that numerous cell cycle genes are down-
regulated upon UHRF1 knockdown (Figure 5b),
which would not be predicted to result from reduced
promoter methylation, we investigated additional
mechanisms by which UHRF1 loss may impede cell
cycle progression.
UHRF1 is required for DNA replication factory
formation evident by the punctate PCNA
immunostaining pattern
Given that Uhrf1-knockout basal cells could not
proliferate in response to the injury, and the RNA-seq
data indicate a cell cycle arrest phenotype, we hypo-
thesized that UHRF1 is required for the G1 to S phase
transition. To further study how UHRF1 affects this
transition, we performed cell cycle progression analysis
of IMR90 fibroblasts expressing a control or UHRF1-
targeting shRNA. We used fibroblasts here because
IMR90 cells can be easily synchronized to G1 phase by
removing serum from the culture media. Fibroblasts
were synchronized by serum withdrawal, and EdU
incorporation and DNA content were measured
after release using flow cytometry (Supplementary
Figure S6a). Synchronized cells started to divide after
serum release and reached peak proliferation at 24 h
when most cells were advancing through the first cell
cycle. We observed a robust proliferative defect at 24 h
concomitantly with an increased proportion of cells
in the G1 phase, indicating that UHRF1 is critical
to initiate DNA replication during the first cell
cycle (Supplementary Figure S6b). DNA replication
factories are large protein complexes involved in DNA
replication, which can be visualized by the punctate
immunostaining pattern of the DNA clamp PCNA
[29, 30]. Previous studies have suggested the presence of
UHRF1 in the replication factory together with PCNA
[14, 31], but the impact of UHRF1 on the formation of
DNA replication factories to initiate DNA replication
during the first cell cycle is not well understood,
especially in the primary cells. To determine whether
the observed G1 arrest was a result of cells’ inability to
form the replication machinery in the absence of
UHRF1, we performed immunocytochemical staining
of UHRF1 and PCNA in proliferating HBE cells. In
the early time points after UHRF1 shRNA-lentiviral
infection before UHRF1 knockdown had occurred,
S phase cells were observed to have overlapping,
Basal stem cell proliferation
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punctate staining patterns for both UHRF1 and
PCNA, indicative of the presence of both proteins in a
complex at the replication fork (Supplementary
Figure S7a). UHRF1 and PCNA also colocalized in
the nuclei of cells expressing a non-targeting shRNA.
In contrast, in HBE cells lacking UHRF1 expression,
PCNA immunostaining was diffuse throughout
the nucleus (Figure 6a), suggesting that UHRF1
is required for the formation of DNA replication
factories in order to initiate DNA synthesis.
To corroborate these findings in vivo, we performed
immunohistochemical staining of the mouse airway
using antibodies specifically recognizing UHRF1 and
PCNA. Uninjured trachea had no detectable expres-
sion of either protein (Supplementary Figure S7b) as
basal cells are normally quiescent. To further explore
whether basal cells enter the first cell cycle at 24 h
after airway injury, we examined UHRF1 and Ki67
expression at 0, 12 and 18 h after injury and found
some of basal cells started to express UHRF1 but not
the proliferation marker Ki67 at 18 h after injury,
indicating that basal cells had exited the quiescent
state and progressed to the G1 phase (Figure 6b and c).
As there was still a small proportion of UHRF1+Ki67−
basal cells at 24 h (Figure 2c and d), these data suggest
that the majority of basal cells undergo their first cell
cycle at 24 h after injury, which is a suitable time point
to assess the impact of UHRF1 deficiency on DNA
replication factory formation.
In control mice at 24 h after injury, we observed
punctate PCNA staining, and PCNA and UHRF1
colocalized in the nuclei of proliferating basal cells
during late S phase, as indicated by large PCNA puncta
(Figure 6d, white arrows). Importantly, deletion of
Uhrf1 using tamoxifen-mediated CreER activation
completely abolished the punctate staining pattern of
PCNA in cells lacking UHRF1 (Figure 6e and f),
confirming the necessity of UHRF1 to promote the
formation of DNA replication factories to activate
DNA replication in response to tracheal injury.
Interestingly, Uhrf1 deletion did not affect PCNA
expression in the nucleus, but inhibited active replica-
tion machinery formation as indicated by the loss of
PCNA puncta (Figure 6e and f). The formation of
DNA replication factories is a multi-step process
involving the licensing of replication origins, assembly
Figure 5 UHRF1 knockdown in HBE cells results in a senescence-associated gene expression signature and global DNA
hypomethylation. (a) Heat map of downregulated and upregulated genes using two independent shRNAs. (b, c) Most highly
represented molecular pathways altered as a result of UHRF1 depletion based on gene ontology analysis. (d) HeLa cells were
treated with 0, 0.1 or 1 μM 5-Aza for 1 week and genomic DNA was extracted. 5-methylated cytosine (5-MeC) levels were
measured by DNA dot blot assay and total DNA was stained with methylene blue. (e) Genomic DNA was extracted from control
and UHRF1 knockdown HBE cells, and the same procedure was used to determine the ratio of 5-MeC to total DNA as indicated
for each condition.
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of a pre-initiation complex and activation of pre-
initiation complexes to form functional replisomes
[32]. Our data do not provide evidence to reveal which
of these steps are directly impacted by UHRF1 loss.
Using a chromatin fractionation assay, we have pre-
liminary data to show that UHRF1 loss does not affect
the loading of ORC2 and several MCM factors to
chromatin and thus is unlikely to regulate replication
origin licensing (data not shown). How UHRF1
modulates the assembly of DNA replication factories
warrants further investigation.
Discussion
In this study, we found that UHRF1 is a critical
regulator of the senescent state in vitro and that loss of
Figure 6 UHRF1 is prerequisite for the DNA replication factory formation. (a) Representative confocal images of control and
UHRF1 knockdown cells co-stained with the indicated antibodies. Cells were collected 3 days after virus transduction when
UHRF1 expression began to decrease. (b, c) Both UHRF1 and Ki67 expression in basal cells were examined at early time points
after airway injury and quantification of cells with different UHRF1 and Ki67 expression levels were shown in c. These data
indicate that 24-h post-injury was the time point when basal cells progressed to the S phase in the first cell cycle. Scale bar:
20 μm. (d, e) Representative confocal images of the tracheal epithelium from K5-CreER mice or Uhrf1fl/fl;K5-CreER mice 24 h
after SO2 injury stained with the indicated antibodies. Top panels are projections generated from z-stack confocal images. Bottom
panels are z-direction images. White arrowheads indicate cells without punctate PCNA staining patterns. Brown arrows indicate
cells with punctate staining pattern in early to middle S phase. White arrows indicate cells with punctate staining pattern in late S
phase. (f) Quantification of the percentages of UHRF1 status in punctate PCNA cells. Scale bar: 10 μm.
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UHRF1 induces the irreversible cell cycle arrest of
basal cells and impairs airway regeneration in vivo.
Using a genetically engineered mouse model, we
provide the first evidence to dissect the function of
UHRF1 in airway basal stem cells. Loss-of-function
experiments in vivo and in vitro suggest that UHRF1
sustains the proliferation and self-renewal of basal
cells but does not control lineage choices related to
differentiation or apoptotic cell death.
In previously published studies utilizing Uhrf1 con-
ditional knockout mouse models, UHRF1 was shown
to target multiple downstream pathways resulting in
diverse biological functions. For example, UHRF1
suppresses Cdkn1a expression through DNA methy-
lation to facilitate the expansion of colonic regulatory
T cells. In invariant natural killer T cells, UHRF1
positively regulates the Akt–mammalian target of
rapamycin (mTOR) pathway to promote survival and
effector differentiation, possibly independent of its
DNA methylation function, whereas UHRF1 controls
the cell fate specification of hematopoietic stem cells
and protects them from erythroid-biased differentia-
tion by epigenetically suppressing the expression of
several differentiation genes. Here, we found that
UHRF1 regulates the regeneration of airway basal
cells by promoting proliferation after airway injury,
suggesting that the functions of UHRF1 are largely cell
type specific.
There are several possible explanations for these
distinct roles of UHRF1 in different cell types. One
possibility is that UHRF1 has tissue-specific targets,
which could be revealed by genome-wide chromatin
immunoprecipitation sequencing or RNA sequencing.
This approach would further help to address the
functional differences between UHRF1 and DNMT1,
as UHRF1 has been reported to act as a transcriptional
activator independent of its role in DNA methylation
[33, 34]. Second, we speculate that intrinsic differences
in cell cycle regulatory mechanisms are likely to result
in discrete UHRF1 functions in the control of cell
proliferation. Murine embryonic stem cells can pro-
liferate indefinitely and lack the cell cycle-dependent
Cdk/cyclin activity that is associated with the G1 to S
transition in normal somatic cells [35]. Uhrf1− /−
embryonic stem cells have been reported to proliferate
normally [14], whereas Uhrf1− /− airway basal cells
arrest in the G1 phase and cannot progress to the S
phase, indicating that UHRF1 may affect the activity
of cyclin-dependent kinases controlling the G1/S
transition partially through the p15 pathway in basal
cells. Additional mechanisms may also exist to prevent
Uhrf1− /− cells from entering the G1/S transition so that
active replication complexes cannot form to initiate
DNA replication. We did not observe a DNA damage
response triggered by DNA replication stress, which is
consistent with the lack of active replisomes in
UHRF1-deficient cells. Detailed biochemical studies
are required to determine the precise mechanism by
which UHRF1 loss triggers the G1/S checkpoint.
A future avenue of investigation concerns the
molecular mechanism by which UHRF1 is down-
regulated in senescent cells. Previous studies on
UHRF1 gene regulation focused mainly on the
mechanisms underlying cell cycle-dependent control of
UHRF1 expression. The transcription factor E2F1 has
been reported to bind to the first intron of UHRF1 to
positively regulate transcription [36]. A separate study
showed that CDK1-meditated phosphorylation of
UHRF1 results in release from the deubiquitylase
USP7 and subsequent proteasomal degradation during
M phase [37]. As our data and other published data sets
have shown that UHRF1 mRNA is decreased in
multiple senescent contexts, we speculate that UHRF1
downregulation is mainly because of the sequester of
E2F1 by hypo-phosphorylated retinoblastoma protein
(RB), which has been commonly observed in senescent
cells. This mechanism may also explain the dynamic
UHRF1 expression in basal cells after airway injury,
which is tightly correlated with cell proliferation.
In conclusion, our study comprehensively outlines
the mechanistic basis of UHRF1-mediated senescence
suppression, which consists of both proper assembly of
the replication machinery as well as maintenance of
epigenetic patterns subsequent to DNA synthesis. As
this epigenetic signaling network inhibits the senescent
cell fate in mammalian stem cell populations, it could
have important implications for diseases broadly
related to stem cell dysfunction and the ageing process.
Materials and Methods
Animals
Uhrf1flox/flox (Uhrf1 fl/fl) mice were kindly provided by
Dr Haruhiko Koseki in the RIKEN Center for Integrative
Medical Sciences. In Uhrf1fl/fl mice, exon 4 and exon 5 were
flanked by loxP sites [17]. K5-CreER mice were kindly provided
by Dr Brigid Hogan in the Department of Cell Biology at Duke
University, Durham, NC, USA. The CreERT2 fragment,
driven by the internal ribosome entry site, was placed into the
3′-untranslated region of Krt5 gene [38]. All mice were main-
tained on a C57BL/6 background. To induce Uhrf1 deletion in
basal cells, male mice 8- to 12-week old were intraperitoneally
injected with four doses of Tmx (75 μg g−1 of body weight) every
other day. One week after the final dose, mice were exposed to
500 p.p.m. of SO2 in air for 4 h. All experiments were approved
by the Duke Institutional Animal Care and Use Committee.
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Cell culture
Primary HBE cells were obtained from dead healthy donors
under a University of North Carolina Biomedical Institutional
Review Board-approved protocol (03-1396). P0 cells were
cultured in plastic dishes coated with bovine collagen in basal
epithelial growth medium (Lonza, Walkersville, MD, USA).
Confluent P0 cells were subsequently passaged into dishes
without collagen and frozen down for experiments. For repli-
cative senescent cells, HBE cells were kept passaging for 80 days
when HBE cells stopped growing and had elevated SA-β-gal
activity. Human diploid fibroblasts IMR90 cells were cultured in
Eagle's minimum essential medium supplemented with 10% fetal
bovine serum and 1×penicillin streptomycin. 293T cells were
maintained in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum.
For bronchosphere culture, spheres were cultured in 0.4-μm
pore size polyester membranes in 24-well, 6.5-mm Transwell
inserts (Corning, Tewksbury, MA, USA). In all, 100 μl of 100%
Matrigel (BD Biosciences, San Jose, CA, USA) was first added
to the apical surface of an insert as a cushion. In all, 1 200 HBE
cells mixed with 24 000 MRC-5 (ATCC, CCL-171) human lung
fibroblasts in 100 μl of 50% ALI/50% Matrigel were added on
the top of the cushion. ALI media were added to the lower
chamber and changed every other day. The pan-caspase inhi-
bitor Z-VAD-FMK was added to the ALI media and changed
every other day for 7 days. The concentration of this compound
was 10 μM. For immunohistochemistry, spheres were fixed with
4% (wt/vol) paraformaldehyde (PFA) in phosphate-buffered
saline (PBS) for 30 min at room temperature and then embed-
ded in paraffin. Three independent experiments were performed
using HBE cells from three different donors. Images were taken
by EVOS microscopy, Thermo Scientific, Asheville, NC, USA
at indicated time points.
For ALI culture, the same inserts were used and coated with
collagen IV (C7521; Sigma-Aldrich, St Louis, MO, USA). In all,
33 000 cells were seeded into inserts. ALI media were applied in
both lower chamber and inserts. When the culture became
confluent 1 week after seeding, media were removed from inserts
and left dry. For whole-mount staining, ALI cultures were
washed with PBS for three times and fixed in 4% (wt/vol) PFA in
room temperature for 10 min.
Plasmid and lentivirus
The control shRNA and the shRNA constructs targeting
UHRF1 were transduced into cells using PLKO.1-puro lenti-
virual vector. All shRNA constructs were purchased from
Sigma-Aldrich. The guide sequences of the shRNAs used in this
study are as follows: shU_1, 5′-CGTCATTTACCACGTGA
AATA-3′; shU_2, 5′-CCGCACCAAGGAATGTACCAT-3′.
For the CRISPR/Cas9-mediated gene knockout experiment,
the lentiCRISPR v2 construct from Dr Feng Zhang’s lab was
purchased fromAddgene (Cambridge, MA, USA) [39]. UHRF1
sgRNA_1: 5′-CGCCGACACCATGTGGATCC-3′; UHRF1
sgRNA_2, 5′-ACACCATGTGGATCCAGGTT-3′. To over-
express H-Ras to induce senescence, H-Ras V12 was cloned into
a Tet-on inducible plasmid. In all, 12 μg of individual shRNA,
lentiCRISPR v2 or the tet-on construct, 9 μg of ps-PAX2 and
3 μg of vesicular stomatitis virus G glycoprotein (VSV-G)
expressing plasmids were co-transfected into 293T cells using
Lipofectamine 2000 (Thermo Fisher Scientific, Asheville, NC,
USA) based on the manual. Viruses were collected 48 h after
transfection. For HBE cells, when cells reached 40% confluency,
viruses were applied for 8 h with 2 μg ml−1 polybrene. For
IMR90 cell virus transduction, cells were infected with viruses
for 18 h at 40% confluency with 4 μg ml−1 polybrene. Forty-eight
hours after virus transduction, stable UHRF1 knockdown cells
were selected using puromycin (0.5 μg ml−1 for HBE cells;
1 μg ml−1 for IMR90 cells) for 2 days. For the tet-on system,
IMR90 fibroblasts were infected with viruses for 18 h at 40%
confluency with 4 μg ml−1 polybrene. After 3-day puromycin
selection, the final concentration of 1 μg ml−1 Dox was added for
8 days to induce senescence, and cells were collected for sub-
sequent experiments.
EdU staining
Cells were incubated with 10 μM EdU for 2 h at 37 °C.
Spheres were incubated with 10 μM EdU for 5 h at 37 °C.
(EdU staining kit, Thermo Fisher Scientific) was performed
using either Click-iT EdU flow cytometry assay kit or Click-iT
EdU imaging kit according to the manufacturer’s protocol.
Annexin V and PI staining
Cells were harvested and immediately stained with Alexa
Fluor 488 Annexin V/Dead Cell Apoptosis Kit (Thermo Fisher
Scientific). Flow cytometry was performed in the Duke Cancer
Center shared flow cytometry facility.
Cell cycle analysis
Cells were incubated with 10 μM EdU for 2 h and then
fixed on 4 °C for 1 h by using the Foxp3/Transcription Factor
Fixation Permeabilization Concentrate and Diluent buffer
(eBioscience, catalogue number: 00-5521-00, Thermo Scientific
Fisher). Subsequently, cells were stained with Click-iT EdU flow
cytometry kit and treated with RNases before staining with PI
for 30 min in room temperature.
Western blot
Total protein was extracted using 0.9% NP-40, 1mM EDTA,
50mM Tris-HCl, 50mM NaCl (NETN) buffer supplemented
with protease inhibitor cocktails (Thermo Fisher
Scientific). Lysates were first sonicated and centrifuged at
12 000 r.p.m. for 10 min. Supernatant was collected and boiled
in loading buffer for 10 min. In all, –30 μg protein samples
were loaded on denaturing sodium dodecyl sulfate gels
and transferred to nitrocellulose membranes (Millipore, Bill-
erica, MA, USA). Membranes were blocked in 5% bovine serum
albumin tris-buffered saline, 0.1% Tween 20 (TBST) and pro-
bed with following antibodies: primary antibody anti-UHRF1
(BD, San Jose, CA, USA, 612264, 1:1 000), p21 (Cell Signaling,
Danvers, MA, USA, 2947, 1:1 000), p15 (Santa Cruz, Dallas,
TX, USA, sc-612, 1:1 000), p16 (BD, 51-1325GR, 1:1 000), p53
(Santa Cruz, sc-126, 1:1 000), secondary antibody labeled by
horseradish peroxidase (Invitrogen). The secondary antibody
was visualized using a chemiluminescent reagent Pierce ECL kit
(Thermo Fisher Scientific).
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Immunofluorescence and immunohistochemistry
For PCNA staining, HBE cells or IMR90 cells transduced
with either scramble or UHRF1-targeting shRNA were fixed in
ice-cold methanol for 5 min in room temperature. Cells were
blocked with serum-free buffer (DAKO, Carpinteria, CA, USA)
with 0.1% Triton X-100 and incubated with the following anti-
bodies: primary anti-PCNA (Santa Cruz, sc-7907, 1:200), anti-
UHRF1 (Santa Cruz, sc-373750, 1:100) and secondary antibody
conjugated with different Alexa fluorophores (Invitrogen).
Mouse tracheas were fixed in 4% (wt/vol) paraformaldehyde in
PBS at 4°C for 3 h, washed with PBS and paraffin embedded.
Tracheas were sectioned longitudinally at 7 μm. For the antigen
retrieval step, paraffin sections were soaked in 10-mM sodium
citrate butter, pH 6, in a pressure cooker-like device (Biocare
Medical, Pacheco, CA, USA). For ALI whole-mount staining,
membranes were stripped off from the inserts and fixed in 4%
paraformaldehyde for 10 min in room temperature. Antibodies
included anti-UHRF1 (Santa Cruz, sc-373750, 1:50), anti-
KRT5 (Covance, Denver, CO, USA, 1:1 000), anti-KRT8
(DSHB, Iowa City, IO, USA, TROMA-I, 1:200), anti-Ki67
(Abcam, Cambridge, MA, USA, ab15580, 1:1 000), anti-PCNA
(Santa Cruz, sc-7907, 1:50), MUC5A (Lab Vision, Fremont,
CA, USA, MS145-PO,1:200), acetylated tubulin (Sigma;
T-7451, 1:1 000). Alexa Fluor-labeled secondary antibodies
(Invitrogen) were used at a 1:400 dilution. All immuno-
fluorescent images were recorded by Zeiss 780 confocal upright
fixed stage confocal microscope with 20×/0.80 Dry Zeiss Plan-
Apochromat objective or 63×/1.4 Oil Zeiss Plan-Apochromat
objective at room temperature. The acquisitions were performed
with Zen software (Carl Zeiss, Dublin, CA, USA). Subsequent
images were rotated, cropped and contrast adjusted using the
ImageJ software. The Imaris software was used for three-
dimensional reconstruction.
SA-β-gal assays
SA-β-gal assay was performed as previously described [21].
For the cytochemical assay, control or UHRF1 knockdown
HBE cells or IMR90 cells were washed twice in PBS and then
fixed using 2% formaldehyde and 0.2% glutaraldehyde in
PBS for 5 min at room temperature. Cells were subsequently
stated with 40 mM citric acid/sodium phosphate buffer (pH 6.0),
5 mM potassium ferrocyanide, 5 mM potassium ferracyanide,
150 mM NaCl, 2 mM MgCl2 and 1 mg ml
−1 X-Gal, typically 8-h
overnight at 37 °C. Microscopic analyses were performed using
an Olympus CK40 microscope (Center Valley, PA, USA) with
DP20 camera. Three fields were counted for each group.
Experiments were repeated three times using cells from
three different donors. For the fluorescence-activated cell
sorting-based sorting of senescent cells, we added C12FDG, a
substrate that produces a fluorescent product upon cleavage
by SA-β-gal, to the culture medium and subsequently
sorted out different cells populations based on fluorescent
intensity [21].
DNA methylation analysis by bisulfite sequencing
Genomic DNA was extracted and purified with DNA
Isolation kit (Qiagen, Santa Clarita, CA, USA). In all, 1 μg
genomic DNA was used for bisulfite conversion using the
MethylDetector Kit (Active Motif, Carlsbad, CA, USA). All
procedures were based on the manufacturer’s instruction. The
converted DNA was then amplified by PCR using EpiMark Hot
Start Taq DNA Polymerase (New England, Ipswich, MA, USA).
Bisulfite sequencing primers are designed based on Methprimer
online software [40]. Forward PCR primer: 5′-GTTTGGATT
GTTTTTGGGAAAAAG-3′; reverse PCR primer: 5′-CCT
AACATCTTTAAACAAACTTCCCC-3′. Subsequently, the
PCR products were subcloned into pCR 2.1-TOPO vector
(Invitrogen) according to the manual. Five clones were picked up
for each experimental group and sent out for sequencing.
RNA-sequencing and gene ontology analysis
RNAs from control and UHRF1 knockdown groups
were extracted by RNeasy Mini Kit (Qiagen). RNA-seq library
preparation, sequencing and analysis were done by Beijing
Genomics Institute (Shenzhen, Guangdong, China). Differen-
tially expressed genes were estimated by using NOIseq method
[41]. Genes with probability ⩾ 0.8 and fold change42 between
control and knockdown groups were considered significantly
changed. For gene ontology analysis, to find more genes that are
changed in both shRNAs, we lowered probability to 0.7 and
found 89 downregulated genes and 84 upregulated genes.
Those genes were then subjected to PANTHER Classification
System [42].
Statistical analysis
Unless otherwise indicated, Student’s t-tests were used for all
statistical analyses. Data are reported as mean± s.e.m.
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